Kyle Cherry
Director Facilities Engineering at Regeneron Pharmaceuticals, Inc.
📍 Rensselaer, New York, United States
Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.
Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.
Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.
Experience
26 Years
Current Role
Director Facilities Engineering
Job Level
Mid-senior
Location
Rensselaer, New York, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Kyle cares about
Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Career
Work history
1-2018
Director Facilities Engineering
Regeneron Pharmaceuticals, Inc.
1-2015 - 1-2018
Associate Director Facilities Engineering
Regeneron Pharmaceuticals, Inc.
4-2014 - 1-2015
Manager Facilities Engineering
Regeneron Pharmaceuticals, Inc.
4-2013 - 4-2014
Manager IOPS Capital Projects
Regeneron Pharmaceuticals, Inc.
8-1999 - 4-2013
Facilities Engineer/Engineering Project Manager
Regeneron Pharmaceuticals, Inc.
In the press
Media appearances
Media appearances and press coverage highlighting public visibility and thought leadership.
Login to viewLogin to view media
Education
1991 - 1995
Bachelor of Science (BS)
Rensselaer Polytechnic Institute
1991 - 1995
Bachelor of Science (BS)
Rensselaer Polytechnic Institute
Social presence
Other Regeneron Pharmaceuticals, Inc. Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.